Ignite Creation Date:
2024-05-06 @ 6:58 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05853354
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-26
First Post:
2023-05-02
Brief Title:
Comparative Efficacy Safety PK and Immunogenicity Study
Sponsor:
Luye Pharma Group Ltd
Organization:
Luye Pharma Group Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Osteoporosis Postmenopausal |
Keywords:
| Name | View |
|---|---|
| Comparative efficacysafetyPK immunogenicity biosimilar | View |